ArticlePharmacology research & perspectives2015

Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial.

Joanna C Betts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.